# Apogee Therapeutics, Inc. (APGE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/APGE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -159.97M | $ -126.95M | $ 6.83M | $ 1.19B |
| 2025 | $ 0 | $ -261.96M | $ -238.16M | $ 8.85M | $ 903.88M |
| 2024 | $ 0 | $ -191.45M | $ -181.13M | $ 11.83M | $ 716.79M |
| 2023 | $ 0 | $ -90.81M | $ -81.02M | $ 2.03M | $ 379.91M |
| 2022 | $ 0 | $ -44.44M | $ -18.35M | $ 0 | $ 142.08M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 26.44 |

## Other views

- [Metrics](https://sponda.capital/en/APGE.md)
- [Charts](https://sponda.capital/en/APGE/charts.md)
- [Compare](https://sponda.capital/en/APGE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.